October 9, 2018

Mylan Recovers From An Early Punch To the Gut

Mylan (MYL) was quite active in trading today, especially given the generally neutral trading activity of the overall marketplace. At market open, the stock was pressured to the downside off of negative commentary from Morgan Stanley. The company stated that Mylan was unlikely to benefit from current positive developments due to “uncertain prospects” on future product sales and pipeline development with sector trends in mind. However, after initially declining, the stock began to sharply recover near the middle of the session. Here’s a recap of what happened.

about the author:

Mike Patton

Mike Patton took the leap into the markets beginning as a commodities broker in 2005, where he was responsible for identifying trading opportunities and executing trades on behalf of clients. After years as a broker he made the jump to education by joining the team at Trading Advantage, now Prosper Trading Academy.

Read Similar Articles

December 17, 2018

Where Is The Market Going?

Friday’s extreme weakness continued into Monday as I suggested would happen late last week. There is always the possibility of a short-term reprieve with news occurring over the weekend, but that didn’t happen to put a bid under the market Monday morning. Stocks plummeted to new lows again. Where may it be headed? February lows […]

Read Article
December 17, 2018

Johnson & Johnson’s Unbalanced Put Fly

Today, we take a look at Johnson & Johnson ($JNJ), its massive increase in implied volatility and more.  Check out the video below to hear what I had to say. Follow me on Twitter: @cboesib

Read Article
December 17, 2018

Clovis Oncology (CLVS)

The US equities markets were quite depressed today, with most indexes firmly lower through most of the session. The S&P 500 etf SPY was down over -1.70%, the healthcare etf XLV was down over -2%, and the biotech etf IBB was down over -1%. Concern about rising interest rates appears to be one of the […]

Read Article

Read Similar Articles

December 17, 2018

Where Is The Market Going?

Friday’s extreme weakness continued into Monday as I suggested would happen late last week. There is always the possibility of a short-term reprieve with news occurring over the weekend, but that didn’t happen to put a bid under the market Monday morning. Stocks plummeted to new lows again. Where may it be headed? February lows […]

Read Article
December 17, 2018

Johnson & Johnson’s Unbalanced Put Fly

Today, we take a look at Johnson & Johnson ($JNJ), its massive increase in implied volatility and more.  Check out the video below to hear what I had to say. Follow me on Twitter: @cboesib

Read Article
December 17, 2018

Clovis Oncology (CLVS)

The US equities markets were quite depressed today, with most indexes firmly lower through most of the session. The S&P 500 etf SPY was down over -1.70%, the healthcare etf XLV was down over -2%, and the biotech etf IBB was down over -1%. Concern about rising interest rates appears to be one of the […]

Read Article